Michigan Heart and Vascular Specialists
Petoskey, Michigan, United States
Cardiologist in Petoskey, Michigan
560 W Mitchell St, Petoskey, MI 49770
About Michigan Heart and Vascular Specialists
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bristol-Myers Squibb
2
Pfizer
1
Clinical Trials at Michigan Heart and Vascular Specialists
During the past decade, Michigan Heart and Vascular Specialists conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
2006-12-31
2011-05-25
Completed
20,976
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
2007-08-31
2017-05-25
Completed
6,421
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
2013-10-29
2017-07-10
Completed
2,139
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Michigan Heart and Vascular Specialists"
#1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Michigan Heart and Vascular Specialists
According to Clinical.Site data, the most researched conditions in "Michigan Heart and Vascular Specialists" are
"Atrial Fibrillation" (2 trials), "Atrial Flutter" (1 trials) and "Hyperlipidemia" (1 trials). Many other conditions were trialed in "Michigan Heart and Vascular Specialists" in a lesser frequency.
Clinical Trials Intervention Types at Michigan Heart and Vascular Specialists
Most popular intervention types in "Michigan Heart and Vascular Specialists" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Acetylsalicylic acid" (1 trials), "Apixaban" (1 trials), "Bococizumab (PF-04950615; RN316)" (1 trials), "Placebo" (1 trials) and "apixaban" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Michigan Heart and Vascular Specialists
The vast majority of trials in "Michigan Heart and Vascular Specialists" are
3 trials for "All" genders.
Clinical Trials Status at Michigan Heart and Vascular Specialists
Currently, there are NaN active trials in "Michigan Heart and Vascular Specialists".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Michigan Heart and Vascular Specialists,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Michigan Heart and Vascular Specialists, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".